Pharmacological characterization of linaprazan glurate (X842), a novel potassium-competitive acid blocker, in vitro and in vivo.
Saved in:
| Title: | Pharmacological characterization of linaprazan glurate (X842), a novel potassium-competitive acid blocker, in vitro and in vivo. |
|---|---|
| Authors: | Lu M; Sinorda Pharmaceuticals Ltd., Jing Yang Hi-Tech Park, Guiyang, Guizhou, China., Cui Y; Clinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China., Li N; Department of Medicine-Solna, Clinical Pharmacology Group, Karolinska University Hospital-Solna, Karolinska Institutet, Stockholm, Sweden., He Y; Good Clinical Practice Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China., Zhou L; Sinorda Pharmaceuticals Ltd., Jing Yang Hi-Tech Park, Guiyang, Guizhou, China., Xiu J; Sinorda Pharmaceuticals Ltd., Jing Yang Hi-Tech Park, Guiyang, Guizhou, China.; Clinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.; Department of Generic, Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden., Hu P; Sinorda Pharmaceuticals Ltd., Jing Yang Hi-Tech Park, Guiyang, Guizhou, China.; Clinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Sep 05; Vol. 16, pp. 1636523. Date of Electronic Publication: 2025 Sep 05 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2025.1636523 |
